Cargando…
Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
OBJECTIVE: To compare baseline characteristics, clinical presentations and outcomes of patients with rheumatic conditions requiring hospitalization for coronavirus disease 2019 (COVID-19) who received chronic HCQ with those who did not receive chronic HCQ. METHODS: We identified all patients with a...
Autores principales: | Pham, Khanh, Torres, Heidi, Satlin, Michael J, Goyal, Parag, Gulick, Roy M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989153/ https://www.ncbi.nlm.nih.gov/pubmed/33875975 http://dx.doi.org/10.1093/rap/rkab014 |
Ejemplares similares
-
Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Singh, Dilpreet K, et al.
Publicado: (2019) -
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
por: Satlin, Michael J., et al.
Publicado: (2020) -
How to Effectively Support Patients with Rheumatic Conditions Now and Beyond COVID‐19
por: Décary, Simon, et al.
Publicado: (2020) -
COVID-19-related anxiety trajectories in children, young people and adults with rheumatic diseases
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2023) -
Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series
por: Malik, Mariam, et al.
Publicado: (2023)